Global Hyperimmune Globulin Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

Hyperimmune Globulin is a highly concentrated immunoglobulin containing high levels of specific antibodies used for passive immunotherapy. It is usually extracted from the plasma of recovered patients who have been infected with a specific pathogen, so these people have produced high levels of antibodies against the pathogen.

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

According to our (Global Info Research) latest study, the global Hyperimmune Globulin Injection market size was valued at US$ 2121 million in 2023 and is forecast to a readjusted size of USD 3270 million by 2030 with a CAGR of 6.3% during review period.

The human plasma-based hyperimmune preparation market is driven by the increasing demand for effective treatments against specific infectious diseases and other medical conditions. Hyperimmune preparations are derived from the plasma of individuals who have recovered from a particular infection or have been vaccinated against a specific pathogen. These preparations contain high levels of antibodies targeting the specific pathogen or antigen, making them valuable for passive immunization in individuals at risk or currently affected by the same disease. The growing prevalence of infectious diseases, such as COVID-19, and the need for rapid and targeted therapeutic solutions have fueled market growth. Moreover, advancements in plasma fractionation and purification technologies have improved the production and safety of hyperimmune preparations. However, the market also faces challenges, including the complexity of large-scale plasma collection and processing, ensuring consistent antibody levels in the preparations, and maintaining a robust supply chain to meet demand during disease outbreaks or pandemics. Additionally, regulatory considerations and the need for stringent safety and quality standards are crucial challenges for manufacturers. To succeed in this market, companies must focus on research and development to expand the applications of hyperimmune preparations, collaborate with healthcare authorities and organizations to establish guidelines and protocols, and work towards enhancing plasma collection infrastructure to ensure a steady supply of human plasma-based hyperimmune preparations for critical therapeutic interventions.

This report is a detailed and comprehensive analysis for global Hyperimmune Globulin Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Hyperimmune Globulin Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Hyperimmune Globulin Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Hyperimmune Globulin Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Hyperimmune Globulin Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hyperimmune Globulin Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hyperimmune Globulin Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Biotest, Kedrion, Emergent, Kamada, CNBG, Hualan Bio, Shanghai RAAS, CBPO, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Hyperimmune Globulin Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Hepatitis B Immuneglobulins
    Rabies Immuneglobulins
    Tetanus Toxin Immuneglobulins
    Rho(D) Immune Globulin
    Cytomegalovirus Immune Globulin
    Varicella-Zoster Immune Globulin
    Others

Market segment by Application
    Government Institution
    Private Sector
    Others

Major players covered
    CSL Behring
    Grifols
    Biotest
    Kedrion
    Emergent
    Kamada
    CNBG
    Hualan Bio
    Shanghai RAAS
    CBPO
    Sichuan Yuanda Shuyang
    ADMA Biologics

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hyperimmune Globulin Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hyperimmune Globulin Injection, with price, sales quantity, revenue, and global market share of Hyperimmune Globulin Injection from 2019 to 2024.
Chapter 3, the Hyperimmune Globulin Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hyperimmune Globulin Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Hyperimmune Globulin Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hyperimmune Globulin Injection.
Chapter 14 and 15, to describe Hyperimmune Globulin Injection sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Hyperimmune Globulin Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Hepatitis B Immuneglobulins
        1.3.3 Rabies Immuneglobulins
        1.3.4 Tetanus Toxin Immuneglobulins
        1.3.5 Rho(D) Immune Globulin
        1.3.6 Cytomegalovirus Immune Globulin
        1.3.7 Varicella-Zoster Immune Globulin
        1.3.8 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Hyperimmune Globulin Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Government Institution
        1.4.3 Private Sector
        1.4.4 Others
    1.5 Global Hyperimmune Globulin Injection Market Size & Forecast
        1.5.1 Global Hyperimmune Globulin Injection Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Hyperimmune Globulin Injection Sales Quantity (2019-2030)
        1.5.3 Global Hyperimmune Globulin Injection Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 CSL Behring
        2.1.1 CSL Behring Details
        2.1.2 CSL Behring Major Business
        2.1.3 CSL Behring Hyperimmune Globulin Injection Product and Services
        2.1.4 CSL Behring Hyperimmune Globulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 CSL Behring Recent Developments/Updates
    2.2 Grifols
        2.2.1 Grifols Details
        2.2.2 Grifols Major Business
        2.2.3 Grifols Hyperimmune Globulin Injection Product and Services
        2.2.4 Grifols Hyperimmune Globulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Grifols Recent Developments/Updates
    2.3 Biotest
        2.3.1 Biotest Details
        2.3.2 Biotest Major Business
        2.3.3 Biotest Hyperimmune Globulin Injection Product and Services
        2.3.4 Biotest Hyperimmune Globulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Biotest Recent Developments/Updates
    2.4 Kedrion
        2.4.1 Kedrion Details
        2.4.2 Kedrion Major Business
        2.4.3 Kedrion Hyperimmune Globulin Injection Product and Services
        2.4.4 Kedrion Hyperimmune Globulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Kedrion Recent Developments/Updates
    2.5 Emergent
        2.5.1 Emergent Details
        2.5.2 Emergent Major Business
        2.5.3 Emergent Hyperimmune Globulin Injection Product and Services
        2.5.4 Emergent Hyperimmune Globulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Emergent Recent Developments/Updates
    2.6 Kamada
        2.6.1 Kamada Details
        2.6.2 Kamada Major Business
        2.6.3 Kamada Hyperimmune Globulin Injection Product and Services
        2.6.4 Kamada Hyperimmune Globulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Kamada Recent Developments/Updates
    2.7 CNBG
        2.7.1 CNBG Details
        2.7.2 CNBG Major Business
        2.7.3 CNBG Hyperimmune Globulin Injection Product and Services
        2.7.4 CNBG Hyperimmune Globulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 CNBG Recent Developments/Updates
    2.8 Hualan Bio
        2.8.1 Hualan Bio Details
        2.8.2 Hualan Bio Major Business
        2.8.3 Hualan Bio Hyperimmune Globulin Injection Product and Services
        2.8.4 Hualan Bio Hyperimmune Globulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Hualan Bio Recent Developments/Updates
    2.9 Shanghai RAAS
        2.9.1 Shanghai RAAS Details
        2.9.2 Shanghai RAAS Major Business
        2.9.3 Shanghai RAAS Hyperimmune Globulin Injection Product and Services
        2.9.4 Shanghai RAAS Hyperimmune Globulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Shanghai RAAS Recent Developments/Updates
    2.10 CBPO
        2.10.1 CBPO Details
        2.10.2 CBPO Major Business
        2.10.3 CBPO Hyperimmune Globulin Injection Product and Services
        2.10.4 CBPO Hyperimmune Globulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 CBPO Recent Developments/Updates
    2.11 Sichuan Yuanda Shuyang
        2.11.1 Sichuan Yuanda Shuyang Details
        2.11.2 Sichuan Yuanda Shuyang Major Business
        2.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product and Services
        2.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Sichuan Yuanda Shuyang Recent Developments/Updates
    2.12 ADMA Biologics
        2.12.1 ADMA Biologics Details
        2.12.2 ADMA Biologics Major Business
        2.12.3 ADMA Biologics Hyperimmune Globulin Injection Product and Services
        2.12.4 ADMA Biologics Hyperimmune Globulin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 ADMA Biologics Recent Developments/Updates

3 Competitive Environment: Hyperimmune Globulin Injection by Manufacturer
    3.1 Global Hyperimmune Globulin Injection Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Hyperimmune Globulin Injection Revenue by Manufacturer (2019-2024)
    3.3 Global Hyperimmune Globulin Injection Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Hyperimmune Globulin Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Hyperimmune Globulin Injection Manufacturer Market Share in 2023
        3.4.3 Top 6 Hyperimmune Globulin Injection Manufacturer Market Share in 2023
    3.5 Hyperimmune Globulin Injection Market: Overall Company Footprint Analysis
        3.5.1 Hyperimmune Globulin Injection Market: Region Footprint
        3.5.2 Hyperimmune Globulin Injection Market: Company Product Type Footprint
        3.5.3 Hyperimmune Globulin Injection Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Hyperimmune Globulin Injection Market Size by Region
        4.1.1 Global Hyperimmune Globulin Injection Sales Quantity by Region (2019-2030)
        4.1.2 Global Hyperimmune Globulin Injection Consumption Value by Region (2019-2030)
        4.1.3 Global Hyperimmune Globulin Injection Average Price by Region (2019-2030)
    4.2 North America Hyperimmune Globulin Injection Consumption Value (2019-2030)
    4.3 Europe Hyperimmune Globulin Injection Consumption Value (2019-2030)
    4.4 Asia-Pacific Hyperimmune Globulin Injection Consumption Value (2019-2030)
    4.5 South America Hyperimmune Globulin Injection Consumption Value (2019-2030)
    4.6 Middle East & Africa Hyperimmune Globulin Injection Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Hyperimmune Globulin Injection Sales Quantity by Type (2019-2030)
    5.2 Global Hyperimmune Globulin Injection Consumption Value by Type (2019-2030)
    5.3 Global Hyperimmune Globulin Injection Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Hyperimmune Globulin Injection Sales Quantity by Application (2019-2030)
    6.2 Global Hyperimmune Globulin Injection Consumption Value by Application (2019-2030)
    6.3 Global Hyperimmune Globulin Injection Average Price by Application (2019-2030)

7 North America
    7.1 North America Hyperimmune Globulin Injection Sales Quantity by Type (2019-2030)
    7.2 North America Hyperimmune Globulin Injection Sales Quantity by Application (2019-2030)
    7.3 North America Hyperimmune Globulin Injection Market Size by Country
        7.3.1 North America Hyperimmune Globulin Injection Sales Quantity by Country (2019-2030)
        7.3.2 North America Hyperimmune Globulin Injection Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Hyperimmune Globulin Injection Sales Quantity by Type (2019-2030)
    8.2 Europe Hyperimmune Globulin Injection Sales Quantity by Application (2019-2030)
    8.3 Europe Hyperimmune Globulin Injection Market Size by Country
        8.3.1 Europe Hyperimmune Globulin Injection Sales Quantity by Country (2019-2030)
        8.3.2 Europe Hyperimmune Globulin Injection Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Hyperimmune Globulin Injection Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Hyperimmune Globulin Injection Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Hyperimmune Globulin Injection Market Size by Region
        9.3.1 Asia-Pacific Hyperimmune Globulin Injection Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Hyperimmune Globulin Injection Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Hyperimmune Globulin Injection Sales Quantity by Type (2019-2030)
    10.2 South America Hyperimmune Globulin Injection Sales Quantity by Application (2019-2030)
    10.3 South America Hyperimmune Globulin Injection Market Size by Country
        10.3.1 South America Hyperimmune Globulin Injection Sales Quantity by Country (2019-2030)
        10.3.2 South America Hyperimmune Globulin Injection Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Hyperimmune Globulin Injection Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Hyperimmune Globulin Injection Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Hyperimmune Globulin Injection Market Size by Country
        11.3.1 Middle East & Africa Hyperimmune Globulin Injection Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Hyperimmune Globulin Injection Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Hyperimmune Globulin Injection Market Drivers
    12.2 Hyperimmune Globulin Injection Market Restraints
    12.3 Hyperimmune Globulin Injection Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Hyperimmune Globulin Injection and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Hyperimmune Globulin Injection
    13.3 Hyperimmune Globulin Injection Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Hyperimmune Globulin Injection Typical Distributors
    14.3 Hyperimmune Globulin Injection Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Hyperimmune Globulin Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Hyperimmune Globulin Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
 Table 4. CSL Behring Major Business
 Table 5. CSL Behring Hyperimmune Globulin Injection Product and Services
 Table 6. CSL Behring Hyperimmune Globulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. CSL Behring Recent Developments/Updates
 Table 8. Grifols Basic Information, Manufacturing Base and Competitors
 Table 9. Grifols Major Business
 Table 10. Grifols Hyperimmune Globulin Injection Product and Services
 Table 11. Grifols Hyperimmune Globulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. Grifols Recent Developments/Updates
 Table 13. Biotest Basic Information, Manufacturing Base and Competitors
 Table 14. Biotest Major Business
 Table 15. Biotest Hyperimmune Globulin Injection Product and Services
 Table 16. Biotest Hyperimmune Globulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Biotest Recent Developments/Updates
 Table 18. Kedrion Basic Information, Manufacturing Base and Competitors
 Table 19. Kedrion Major Business
 Table 20. Kedrion Hyperimmune Globulin Injection Product and Services
 Table 21. Kedrion Hyperimmune Globulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. Kedrion Recent Developments/Updates
 Table 23. Emergent Basic Information, Manufacturing Base and Competitors
 Table 24. Emergent Major Business
 Table 25. Emergent Hyperimmune Globulin Injection Product and Services
 Table 26. Emergent Hyperimmune Globulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Emergent Recent Developments/Updates
 Table 28. Kamada Basic Information, Manufacturing Base and Competitors
 Table 29. Kamada Major Business
 Table 30. Kamada Hyperimmune Globulin Injection Product and Services
 Table 31. Kamada Hyperimmune Globulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Kamada Recent Developments/Updates
 Table 33. CNBG Basic Information, Manufacturing Base and Competitors
 Table 34. CNBG Major Business
 Table 35. CNBG Hyperimmune Globulin Injection Product and Services
 Table 36. CNBG Hyperimmune Globulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. CNBG Recent Developments/Updates
 Table 38. Hualan Bio Basic Information, Manufacturing Base and Competitors
 Table 39. Hualan Bio Major Business
 Table 40. Hualan Bio Hyperimmune Globulin Injection Product and Services
 Table 41. Hualan Bio Hyperimmune Globulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 42. Hualan Bio Recent Developments/Updates
 Table 43. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
 Table 44. Shanghai RAAS Major Business
 Table 45. Shanghai RAAS Hyperimmune Globulin Injection Product and Services
 Table 46. Shanghai RAAS Hyperimmune Globulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 47. Shanghai RAAS Recent Developments/Updates
 Table 48. CBPO Basic Information, Manufacturing Base and Competitors
 Table 49. CBPO Major Business
 Table 50. CBPO Hyperimmune Globulin Injection Product and Services
 Table 51. CBPO Hyperimmune Globulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 52. CBPO Recent Developments/Updates
 Table 53. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
 Table 54. Sichuan Yuanda Shuyang Major Business
 Table 55. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product and Services
 Table 56. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 57. Sichuan Yuanda Shuyang Recent Developments/Updates
 Table 58. ADMA Biologics Basic Information, Manufacturing Base and Competitors
 Table 59. ADMA Biologics Major Business
 Table 60. ADMA Biologics Hyperimmune Globulin Injection Product and Services
 Table 61. ADMA Biologics Hyperimmune Globulin Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 62. ADMA Biologics Recent Developments/Updates
 Table 63. Global Hyperimmune Globulin Injection Sales Quantity by Manufacturer (2019-2024) & (K Units)
 Table 64. Global Hyperimmune Globulin Injection Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 65. Global Hyperimmune Globulin Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 66. Market Position of Manufacturers in Hyperimmune Globulin Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 67. Head Office and Hyperimmune Globulin Injection Production Site of Key Manufacturer
 Table 68. Hyperimmune Globulin Injection Market: Company Product Type Footprint
 Table 69. Hyperimmune Globulin Injection Market: Company Product Application Footprint
 Table 70. Hyperimmune Globulin Injection New Market Entrants and Barriers to Market Entry
 Table 71. Hyperimmune Globulin Injection Mergers, Acquisition, Agreements, and Collaborations
 Table 72. Global Hyperimmune Globulin Injection Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 73. Global Hyperimmune Globulin Injection Sales Quantity by Region (2019-2024) & (K Units)
 Table 74. Global Hyperimmune Globulin Injection Sales Quantity by Region (2025-2030) & (K Units)
 Table 75. Global Hyperimmune Globulin Injection Consumption Value by Region (2019-2024) & (USD Million)
 Table 76. Global Hyperimmune Globulin Injection Consumption Value by Region (2025-2030) & (USD Million)
 Table 77. Global Hyperimmune Globulin Injection Average Price by Region (2019-2024) & (US$/Unit)
 Table 78. Global Hyperimmune Globulin Injection Average Price by Region (2025-2030) & (US$/Unit)
 Table 79. Global Hyperimmune Globulin Injection Sales Quantity by Type (2019-2024) & (K Units)
 Table 80. Global Hyperimmune Globulin Injection Sales Quantity by Type (2025-2030) & (K Units)
 Table 81. Global Hyperimmune Globulin Injection Consumption Value by Type (2019-2024) & (USD Million)
 Table 82. Global Hyperimmune Globulin Injection Consumption Value by Type (2025-2030) & (USD Million)
 Table 83. Global Hyperimmune Globulin Injection Average Price by Type (2019-2024) & (US$/Unit)
 Table 84. Global Hyperimmune Globulin Injection Average Price by Type (2025-2030) & (US$/Unit)
 Table 85. Global Hyperimmune Globulin Injection Sales Quantity by Application (2019-2024) & (K Units)
 Table 86. Global Hyperimmune Globulin Injection Sales Quantity by Application (2025-2030) & (K Units)
 Table 87. Global Hyperimmune Globulin Injection Consumption Value by Application (2019-2024) & (USD Million)
 Table 88. Global Hyperimmune Globulin Injection Consumption Value by Application (2025-2030) & (USD Million)
 Table 89. Global Hyperimmune Globulin Injection Average Price by Application (2019-2024) & (US$/Unit)
 Table 90. Global Hyperimmune Globulin Injection Average Price by Application (2025-2030) & (US$/Unit)
 Table 91. North America Hyperimmune Globulin Injection Sales Quantity by Type (2019-2024) & (K Units)
 Table 92. North America Hyperimmune Globulin Injection Sales Quantity by Type (2025-2030) & (K Units)
 Table 93. North America Hyperimmune Globulin Injection Sales Quantity by Application (2019-2024) & (K Units)
 Table 94. North America Hyperimmune Globulin Injection Sales Quantity by Application (2025-2030) & (K Units)
 Table 95. North America Hyperimmune Globulin Injection Sales Quantity by Country (2019-2024) & (K Units)
 Table 96. North America Hyperimmune Globulin Injection Sales Quantity by Country (2025-2030) & (K Units)
 Table 97. North America Hyperimmune Globulin Injection Consumption Value by Country (2019-2024) & (USD Million)
 Table 98. North America Hyperimmune Globulin Injection Consumption Value by Country (2025-2030) & (USD Million)
 Table 99. Europe Hyperimmune Globulin Injection Sales Quantity by Type (2019-2024) & (K Units)
 Table 100. Europe Hyperimmune Globulin Injection Sales Quantity by Type (2025-2030) & (K Units)
 Table 101. Europe Hyperimmune Globulin Injection Sales Quantity by Application (2019-2024) & (K Units)
 Table 102. Europe Hyperimmune Globulin Injection Sales Quantity by Application (2025-2030) & (K Units)
 Table 103. Europe Hyperimmune Globulin Injection Sales Quantity by Country (2019-2024) & (K Units)
 Table 104. Europe Hyperimmune Globulin Injection Sales Quantity by Country (2025-2030) & (K Units)
 Table 105. Europe Hyperimmune Globulin Injection Consumption Value by Country (2019-2024) & (USD Million)
 Table 106. Europe Hyperimmune Globulin Injection Consumption Value by Country (2025-2030) & (USD Million)
 Table 107. Asia-Pacific Hyperimmune Globulin Injection Sales Quantity by Type (2019-2024) & (K Units)
 Table 108. Asia-Pacific Hyperimmune Globulin Injection Sales Quantity by Type (2025-2030) & (K Units)
 Table 109. Asia-Pacific Hyperimmune Globulin Injection Sales Quantity by Application (2019-2024) & (K Units)
 Table 110. Asia-Pacific Hyperimmune Globulin Injection Sales Quantity by Application (2025-2030) & (K Units)
 Table 111. Asia-Pacific Hyperimmune Globulin Injection Sales Quantity by Region (2019-2024) & (K Units)
 Table 112. Asia-Pacific Hyperimmune Globulin Injection Sales Quantity by Region (2025-2030) & (K Units)
 Table 113. Asia-Pacific Hyperimmune Globulin Injection Consumption Value by Region (2019-2024) & (USD Million)
 Table 114. Asia-Pacific Hyperimmune Globulin Injection Consumption Value by Region (2025-2030) & (USD Million)
 Table 115. South America Hyperimmune Globulin Injection Sales Quantity by Type (2019-2024) & (K Units)
 Table 116. South America Hyperimmune Globulin Injection Sales Quantity by Type (2025-2030) & (K Units)
 Table 117. South America Hyperimmune Globulin Injection Sales Quantity by Application (2019-2024) & (K Units)
 Table 118. South America Hyperimmune Globulin Injection Sales Quantity by Application (2025-2030) & (K Units)
 Table 119. South America Hyperimmune Globulin Injection Sales Quantity by Country (2019-2024) & (K Units)
 Table 120. South America Hyperimmune Globulin Injection Sales Quantity by Country (2025-2030) & (K Units)
 Table 121. South America Hyperimmune Globulin Injection Consumption Value by Country (2019-2024) & (USD Million)
 Table 122. South America Hyperimmune Globulin Injection Consumption Value by Country (2025-2030) & (USD Million)
 Table 123. Middle East & Africa Hyperimmune Globulin Injection Sales Quantity by Type (2019-2024) & (K Units)
 Table 124. Middle East & Africa Hyperimmune Globulin Injection Sales Quantity by Type (2025-2030) & (K Units)
 Table 125. Middle East & Africa Hyperimmune Globulin Injection Sales Quantity by Application (2019-2024) & (K Units)
 Table 126. Middle East & Africa Hyperimmune Globulin Injection Sales Quantity by Application (2025-2030) & (K Units)
 Table 127. Middle East & Africa Hyperimmune Globulin Injection Sales Quantity by Country (2019-2024) & (K Units)
 Table 128. Middle East & Africa Hyperimmune Globulin Injection Sales Quantity by Country (2025-2030) & (K Units)
 Table 129. Middle East & Africa Hyperimmune Globulin Injection Consumption Value by Country (2019-2024) & (USD Million)
 Table 130. Middle East & Africa Hyperimmune Globulin Injection Consumption Value by Country (2025-2030) & (USD Million)
 Table 131. Hyperimmune Globulin Injection Raw Material
 Table 132. Key Manufacturers of Hyperimmune Globulin Injection Raw Materials
 Table 133. Hyperimmune Globulin Injection Typical Distributors
 Table 134. Hyperimmune Globulin Injection Typical Customers


List of Figures
 Figure 1. Hyperimmune Globulin Injection Picture
 Figure 2. Global Hyperimmune Globulin Injection Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Hyperimmune Globulin Injection Revenue Market Share by Type in 2023
 Figure 4. Hepatitis B Immuneglobulins Examples
 Figure 5. Rabies Immuneglobulins Examples
 Figure 6. Tetanus Toxin Immuneglobulins Examples
 Figure 7. Rho(D) Immune Globulin Examples
 Figure 8. Cytomegalovirus Immune Globulin Examples
 Figure 9. Varicella-Zoster Immune Globulin Examples
 Figure 10. Others Examples
 Figure 11. Global Hyperimmune Globulin Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 12. Global Hyperimmune Globulin Injection Revenue Market Share by Application in 2023
 Figure 13. Government Institution Examples
 Figure 14. Private Sector Examples
 Figure 15. Others Examples
 Figure 16. Global Hyperimmune Globulin Injection Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 17. Global Hyperimmune Globulin Injection Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 18. Global Hyperimmune Globulin Injection Sales Quantity (2019-2030) & (K Units)
 Figure 19. Global Hyperimmune Globulin Injection Price (2019-2030) & (US$/Unit)
 Figure 20. Global Hyperimmune Globulin Injection Sales Quantity Market Share by Manufacturer in 2023
 Figure 21. Global Hyperimmune Globulin Injection Revenue Market Share by Manufacturer in 2023
 Figure 22. Producer Shipments of Hyperimmune Globulin Injection by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 23. Top 3 Hyperimmune Globulin Injection Manufacturer (Revenue) Market Share in 2023
 Figure 24. Top 6 Hyperimmune Globulin Injection Manufacturer (Revenue) Market Share in 2023
 Figure 25. Global Hyperimmune Globulin Injection Sales Quantity Market Share by Region (2019-2030)
 Figure 26. Global Hyperimmune Globulin Injection Consumption Value Market Share by Region (2019-2030)
 Figure 27. North America Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 28. Europe Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 29. Asia-Pacific Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 30. South America Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 31. Middle East & Africa Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 32. Global Hyperimmune Globulin Injection Sales Quantity Market Share by Type (2019-2030)
 Figure 33. Global Hyperimmune Globulin Injection Consumption Value Market Share by Type (2019-2030)
 Figure 34. Global Hyperimmune Globulin Injection Average Price by Type (2019-2030) & (US$/Unit)
 Figure 35. Global Hyperimmune Globulin Injection Sales Quantity Market Share by Application (2019-2030)
 Figure 36. Global Hyperimmune Globulin Injection Revenue Market Share by Application (2019-2030)
 Figure 37. Global Hyperimmune Globulin Injection Average Price by Application (2019-2030) & (US$/Unit)
 Figure 38. North America Hyperimmune Globulin Injection Sales Quantity Market Share by Type (2019-2030)
 Figure 39. North America Hyperimmune Globulin Injection Sales Quantity Market Share by Application (2019-2030)
 Figure 40. North America Hyperimmune Globulin Injection Sales Quantity Market Share by Country (2019-2030)
 Figure 41. North America Hyperimmune Globulin Injection Consumption Value Market Share by Country (2019-2030)
 Figure 42. United States Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 43. Canada Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 44. Mexico Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 45. Europe Hyperimmune Globulin Injection Sales Quantity Market Share by Type (2019-2030)
 Figure 46. Europe Hyperimmune Globulin Injection Sales Quantity Market Share by Application (2019-2030)
 Figure 47. Europe Hyperimmune Globulin Injection Sales Quantity Market Share by Country (2019-2030)
 Figure 48. Europe Hyperimmune Globulin Injection Consumption Value Market Share by Country (2019-2030)
 Figure 49. Germany Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 50. France Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 51. United Kingdom Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 52. Russia Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 53. Italy Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 54. Asia-Pacific Hyperimmune Globulin Injection Sales Quantity Market Share by Type (2019-2030)
 Figure 55. Asia-Pacific Hyperimmune Globulin Injection Sales Quantity Market Share by Application (2019-2030)
 Figure 56. Asia-Pacific Hyperimmune Globulin Injection Sales Quantity Market Share by Region (2019-2030)
 Figure 57. Asia-Pacific Hyperimmune Globulin Injection Consumption Value Market Share by Region (2019-2030)
 Figure 58. China Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 59. Japan Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 60. South Korea Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 61. India Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 62. Southeast Asia Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 63. Australia Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 64. South America Hyperimmune Globulin Injection Sales Quantity Market Share by Type (2019-2030)
 Figure 65. South America Hyperimmune Globulin Injection Sales Quantity Market Share by Application (2019-2030)
 Figure 66. South America Hyperimmune Globulin Injection Sales Quantity Market Share by Country (2019-2030)
 Figure 67. South America Hyperimmune Globulin Injection Consumption Value Market Share by Country (2019-2030)
 Figure 68. Brazil Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 69. Argentina Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 70. Middle East & Africa Hyperimmune Globulin Injection Sales Quantity Market Share by Type (2019-2030)
 Figure 71. Middle East & Africa Hyperimmune Globulin Injection Sales Quantity Market Share by Application (2019-2030)
 Figure 72. Middle East & Africa Hyperimmune Globulin Injection Sales Quantity Market Share by Country (2019-2030)
 Figure 73. Middle East & Africa Hyperimmune Globulin Injection Consumption Value Market Share by Country (2019-2030)
 Figure 74. Turkey Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 75. Egypt Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 76. Saudi Arabia Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 77. South Africa Hyperimmune Globulin Injection Consumption Value (2019-2030) & (USD Million)
 Figure 78. Hyperimmune Globulin Injection Market Drivers
 Figure 79. Hyperimmune Globulin Injection Market Restraints
 Figure 80. Hyperimmune Globulin Injection Market Trends
 Figure 81. Porters Five Forces Analysis
 Figure 82. Manufacturing Cost Structure Analysis of Hyperimmune Globulin Injection in 2023
 Figure 83. Manufacturing Process Analysis of Hyperimmune Globulin Injection
 Figure 84. Hyperimmune Globulin Injection Industrial Chain
 Figure 85. Sales Channel: Direct to End-User vs Distributors
 Figure 86. Direct Channel Pros & Cons
 Figure 87. Indirect Channel Pros & Cons
 Figure 88. Methodology
 Figure 89. Research Process and Data Source

Companies Mentioned

CSL Behring
Grifols
Biotest
Kedrion
Emergent
Kamada
CNBG
Hualan Bio
Shanghai RAAS
CBPO
Sichuan Yuanda Shuyang
ADMA Biologics